ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Caprolactam Chemicals will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window is closed from 1 October 2026.
Caprolactam Chemicals Ltd has filed its quarterly shareholding pattern report under Regulation 31(1)(b) of the SEBI LODR Regulations for the period ended 30 September 2026.
Caprolactam Chemicals Ltd. held its 37th Annual General Meeting on September 28, 2026. Shareholders considered routine items, including financial statements and the appointment of statutory auditors.
Caprolactam Chemicals Ltd. has appointed M/s. Raman S. Shah & Co. as the company's Statutory Auditor for a term of 60 months.
Caprolactam Chemicals internal auditor Shrey Pandey & Associates resigned effective 10 Sept 2026. Parth Patel D & Associates was appointed as the new internal auditor for FY 2026-27.
Caprolactam Chemicals Ltd. has issued a notice for its 37th Annual General Meeting to be held on September 28, 2026, through video conference.
Caprolactam Chemicals Ltd announced the recommendation of M/s. Raman S. Shah & Co as Statutory Auditor and approved the notice and scrutinizer for its 37th AGM.
Caprolactam Chemicals Ltd reported revenue from operations of ₹0.5 Cr (-80.8% YoY) and a net loss of ₹1 Cr for Q1 FY27.
Caprolactam Chemicals Limited has scheduled a board meeting on August 13, 2026. The board will consider unaudited standalone financial results for the quarter ended June 2026.
CAPROLACTAM Chemicals Ltd discloses its shareholding pattern for quarter ending 30 June 2026, detailing promoter, promoter group, and public holdings. The filing complies with Regulation 31(1)(b) requirements.
Caprolactam Chemicals Ltd reported revenue from operations of ₹3.1 Cr (+93.8% YoY) and net profit of ₹0.8 Cr for Q4 FY26.
Caprolactam Chemicals Ltd approved its audited FY2026 financial results, reporting annual total income of ₹10.59 Crore. The board also appointed M/s. Shrey Pandey & Associates as internal auditors.